The impact of spontaneous tumour perforation on outcome following colon cancer surgery

2008 ◽  
Vol 10 (8) ◽  
pp. 775-780 ◽  
Author(s):  
A. S. Abdelrazeq ◽  
N. Scott ◽  
C. Thorn ◽  
C. S. Verbeke ◽  
N. S. Ambrose ◽  
...  
2011 ◽  
Vol 26 (7) ◽  
pp. 875-880 ◽  
Author(s):  
Junichi Hasegawa ◽  
Junichi Nishimura ◽  
Shunsuke Yamamoto ◽  
Youichirou Yoshida ◽  
Kazuhiro Iwase ◽  
...  

2014 ◽  
Vol 29 (9) ◽  
pp. 1143-1150 ◽  
Author(s):  
Raymond Oliphant ◽  
◽  
Gary A. Nicholson ◽  
Paul G. Horgan ◽  
Donald C. McMillan ◽  
...  

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Susanna Niemeläinen ◽  
Heini Huhtala ◽  
Anu Ehrlich ◽  
Jyrki Kössi ◽  
Esa Jämsen ◽  
...  

Abstract Background The number of colorectal cancer patients increases with age. The decision to go through major surgery can be challenging for the aged patient and the surgeon because of the heterogeneity within the older population. Differences in preoperative physical and cognitive status can affect postoperative outcomes and functional recovery, and impact on patients’ quality of life. Methods / design A prospective, observational, multicentre study including nine hospitals to analyse the impact of colon cancer surgery on functional ability, short-term outcomes (complications and mortality), and their predictors in patients aged ≥80 years. The catchment area of the study hospitals is 3.88 million people, representing 70% of the population of Finland. The data will be gathered from patient baseline characteristics, surgical interventional data, and pre- and postoperative patient-questionnaires, to an electronic database (REDCap) especially dedicated to the study. Discussion This multicentre study provides information about colon cancer surgery’s operative and functional outcomes on older patients. A further aim is to find prognostic factors which could help to predict adverse outcomes of surgery. Trial registration ClinicalTrials.gov (NCT03904121). Registered on 1 April 2019.


2017 ◽  
Vol 116 (3) ◽  
pp. 389-397 ◽  
Author(s):  
Christopher T Aquina ◽  
Supriya G Mohile ◽  
Mohamedtaki A Tejani ◽  
Adan Z Becerra ◽  
Zhaomin Xu ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 10012-10012 ◽  
Author(s):  
Christopher Thomas Aquina ◽  
Supriya Gupta Mohile ◽  
Mohamedtaki Abdulaziz Tejani ◽  
Adan Becerra ◽  
Bradley J Hensley ◽  
...  

2013 ◽  
Vol 206 (2) ◽  
pp. 166-171 ◽  
Author(s):  
Ramzi Amri ◽  
Hannah C. den Boon ◽  
Liliana G. Bordeianou ◽  
Patricia Sylla ◽  
David L. Berger

Author(s):  
Kiho You ◽  
Dae Kyung Sohn ◽  
Sung Sil Park ◽  
Sung Chan Park ◽  
Jae Hwan Oh ◽  
...  

2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Yuichiro Furutani ◽  
Chikashi Hiranuma ◽  
Masakazu Hattori ◽  
Kenji Doden ◽  
Yasuo Hashizume

Abstract Background Portal venous gas has traditionally been considered an inevitable harbinger of death due to its association with bowel necrosis. Recently, an increasing number of cases of portal venous gas have been reported in patients with various clinical conditions and without bowel necrosis. We herein report the case of a patient in whom portal venous gas developed after transverse colon cancer surgery. Case presentation A 69-year-old man who had transverse colon cancer underwent insertion of a transanal ileus tube for decompression. Transverse colon resection was performed on the 11th day after the insertion of the transanal ileus tube. The patient had a high fever on the 6th day after the operation. Computed tomography showed portal venous gas over the entire area of the liver and pneumatosis intestinalis in the wall of the ascending colon. There were no signs of anastomotic leakage or bowel necrosis, so we decided to use conservative therapy with fasting and antibiotics. The portal venous gas disappeared on the 19th day after the operation. The patient was discharged in good condition on the 29th day after the operation. Conclusions Conservative treatment for portal venous gas is reasonable for patients without signs of anastomotic leakage or bowel necrosis. However, it is important to carefully observe patients with portal venous gas during conservative treatment because portal venous gas may be life-threatening.


Sign in / Sign up

Export Citation Format

Share Document